Patents (1436 Stem Cell Patents)

Class: Expansion (424)

Order by:
<< | < | 13 14 15 16 17 18 19 20 21 | > | >>


Vasostatin as marrow protectant

Patent Number: 6596690

This patent covers the new use of vasostatin in inhibiting the killing of stem cells from agents that are cytotoxic the mitotic cells such as radiation and chemotherapy.

Inventors: Tosato, Giovanna (Bethesda, MD); Pike, Sandra E. (North Bethesda, MD); Yao, Lei (Rockville, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services
Date of First Priority Issue: Tuesday October 6th, 1998

Methods and devices for the long-term culture of hematopoietic progenitor cells

Patent Number: 6440734

This patent discloses various three dimensional biomaterials that resemble the actual bone marrow microenvironment and are useful for stimulating expansion of hematopoietic stem cells. This patent may be used for expanding autologous stem cells for patients that lack a suitable bone marrow or stem cell donor. Additionally, the ability to expand and grow hematopoietic stem cells can...

Inventors: Pykett, Mark J. (Newton, MA); Rosenzweig, Michael (Boston, MA); Kaplan, Richard B. (Beverly Hills, CA)
Assignee: Cytomatrix, LLC (Woburn, MA)
Date of First Priority Issue: Friday September 25th, 1998

Electroactive materials for stimulation of biological activity of bone marrow stromal cells

Patent Number: 6,190,893

This patent is useful for parties interested in altering the biological activity of stromal cells of the bone marrow, particularly in the area of bioengineering. The invention has 5 independent claims. The first covers a method for stimulating biological activities (gene expression, growth, differentiation, transduction, and combo) in bone marrow stromal cells by contacting with an...

Inventors: Shastri, Venkatram R. (Allston, MA); Rahman, Nahid (Cambridge, MA); Martin, Ivan (Cambridge, MA); Langer, Jr., Robert S. (Newton, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Date of First Priority Issue: Friday September 18th, 1998

Use of fibroblast growth factor 2 for expansion of chondrocytes and tissue engineering

Patent Number: 6582960

This patent teaches that FGF-2 can actually de-differentiate certain cells, and be used for the formation of chondrocytes. This would be useful for cartilage repair, as well as for various tissue regenerative purposes.

Inventors: Martin, Ivan (Basel, CH); Freed, Lisa E. (Belmont, MA); Langer, Robert (Newton, MA); Vunjak-Novakovic, Gordana (Belmont, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Date of First Priority Issue: Friday September 18th, 1998

Electroactive materials for stimulation of biological activity of stem cells

Patent Number: 6569654

This patent teaches ways of stimulating virtually all possible biological activities from mesenchymal stem cells through the contact with electroactive materials.

Inventors: Shastri, Venkatram (Lower Gwynedd, PA); Martin, Ivan (Oberwil, CH); Langer, Robert (Newton, MA); Rahman, Nahid (Boston, MA)
Assignee: Massachusetts Institute of Technology (Cambridge, MA)
Date of First Priority Issue: Friday September 18th, 1998

Serum-free medium for mesenchymal stem cells

Patent Number: 7109032

This patent is useful for parties seeking to expand mesenchymal stem cells, particularly for clinical applications. The invention generally teaches tissue culture media and techniques that alleviate the need for using serum. Since serum is usually from animal origin (fetal calf serum) or in some cases of human origin, there exists possibilities of contaminating cellular sources. The...

Inventors: Cancedda, Ranieri (Genoa, IT); Dozin, Beatrice (Rapallo, IT)
Assignee: Consorzio per la Gestione del Centro di Biotecnologie Avanzate (Genoa, IT); Istituto Nazionale per la Ricerca Sul Cancro (Genoa, IT)
Date of First Priority Issue: Thursday September 10th, 1998

Genes in the control of hematopoiesis

Patent Number: 6451558

This patent covers some genes whose function is not really described in the application. In order to understant the relevance of this patent, one should take the sequence and blast it in genbank to see what the real name of this gene is.

Inventors: Cooke, Michael Paul (Del Mar, CA); Holness, Claire Louise (Palo Alto, CA); Sirenko, Oksana Ivanivna (Belmont, CA)
Assignee: Novartis AG (Basel, CH)
Date of First Priority Issue: Monday August 3rd, 1998

Targeting pharmaceutical agents to injured tissues

Patent Number: 6955898

This patent teaches was of targeting damaged tissue with genes that stimulate angiogenesis. Conceptually the technology could be modified to introduce agents which actually stimulate stem cell proliferation at the site of injury. The patent has one issued claim that covers a fusion polypeptide, with one end having a collagen binding domain which binds exposed vascular collagen (ie during...

Inventors: Hall, Frederick L. (Glendale, CA); Gordon, Erlinda M. (Glendale, CA); Starnes, Vaughn A. (Pasadena, CA); Anderson, W. French (San Marino, CA)
Assignee: University of Southern California (Los Angeles, CA)
Date of First Priority Issue: Friday July 31st, 1998

Method for maintenance and propagation of germline stem cells using members of the TFG-.beta. family of growth factors

Patent Number: 6800790

This patent teaches how to increase the number of germline stem cells in a fruitfly through overexpression of Dpp locally using certain promoters that are specific to germline stem cells. Since the patent is only covering the fruitfly species, clinical applications seem to be limited.

Inventors: Spradling, Allan C. (Baltimore, MD); Xie, Ting (Baltimore, MD)
Assignee: Carnegie Institution of Washington (Washington, DC)
Date of First Priority Issue: Friday July 24th, 1998

Cell expansion system for use in neural transplantation

Patent Number: 6787356

This patent teaches methods of generating and expanding dopaminergic neurons that can be used for treatment of a variety of neurological conditions. The system uses, amongst other things, fibroblast growth factor for expansion.

Inventors: Studer, Lorenz (New York, NY); McKay, Ron D. (Bethesda, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services
Date of First Priority Issue: Friday July 24th, 1998

Order by:
<< | < | 13 14 15 16 17 18 19 20 21 | > | >>

Home | News | Patents | Products | Jobs | Links | Search | Journal | RSS

About | Advisory Board | Newsletter | Advertise | Contact | Sitemap | Privacy Policy | Terms of Use

Copyright © 2006 - 2025 StemCellPatents.com - All rights reserved. - Toronto Web Design

StemCellPatents.com V2.04

Stouffville Concrete | Tottenham Concrete | Uxbridge Concrete | Gerogetown Concrete | Rockwood Concrete | Kleinburg Concrete | Breslau Concrete | Kitchener Concrete | Cambridge Concrete | Caledon Concrete | Milton Concrete | King City Concrete | Mount Albert Concrete | Nobleton Concrete | Bolton Concrete | Stouffville Real Estate Agent